BRCA1-null mutations in ovarian cancer cells induce NF-κB signaling, which causes enhanced transcriptional activation of target genes that promote increased autophagy, glycolysis, and oxidative stress in the stroma [75]. This evidence concerns the gene NFKB1 and ovarian cancer.